LIONEX has special interest in developing a TB Rapid test for TB endemic countries. Our research of the past 18 years has helped us in developing an active TB rapid test showing high specificity of ca. 98% at an overall sensitivity of 65%. Our latest Rapid test called LIODetect®TB-ST has a cocktail of five, highly purified recombinant proteins as well as a native surface antigen of M. tuberculosis coated as a separate line. In an independent evaluation in RUSSIA, this new TB Rapid test has shown much higher sensitivities in Russia, which are in the range as suggested by the Words Health Organisation (WHO). Large scale clinical studies are now in progress in a number of African and Asian countries.

The LIODetect®TB-ST Tuberculosis Rapid Test is an in vitro diagnostic rapid test for the qualitative detection of IgG, IgA and IgM antibodies to Mycobacterium tuberculosis in serum, plasma or whole blood within 20 minutes.

The LIODetect®CRP 10-30 and  LIODetect®CRP 10-60 Rapid Test are tests for the semi-quantitative detection of CRP in serum, plasma or whole blood within 5 minutes (latest 10 min). The tests are intended for professional in vitro diagnostic use only.

The LIODetect®D-Dimer Rapid  Testis  a  rapid, visual  test  for  the  qualitative  detection  of  D-dimer  in  plasma  or  whole  blood within  10min (latest 15min).

The LIODetect® Troponin I Rapid Test is a visual test for the qualitative detection of Troponin I in whole blood, plasma and serum samples within 10min (latest 15min). The test is for professional in vitro diagnostic use only and intended to support the diagnosis of acute myocardial infarction (AMI).

The LD COVID-19 IgG Rapid Testis a visual test for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum, plasma, or whole blood within 15 min (latest 20 min). The test is for professional in vitro diagnostic use only and intended to aid in the diagnosis of SARS-CoV-2 infection and to complement direct pathogen detection. Serology can also be used to collect epidemiological data. The product is intended for use as an IVD but can also be used for research purposes.

The LD COVID-19 IgM Rapid Testis a visual test for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum, plasma, or whole blood within 15 min (latest 20 min). The test is for professional in vitro diagnostic use only and intended to aid in the diagnosis of SARS-CoV-2 infection and to complement direct pathogen detection. Serology can also be used to collect epidemiological data. The product is intended for use as an IVD but can also be used for research purposes.

The COVID-19 Ag Rapid Test is a visual test for the direct and qualitative detection of SARS-CoV-2 viral Spike glycoprotein (S1) in human nasopharynx and/or oropharynx within 15 min (latest 20 min).

The LIODetect®BCT Rapid Testis a rapid, visual test for the qualitative detection of Human transcription factor Engrailed-2 (EN2)as a bladder cancer biomarkerin urinewithin 10min (latest 15min).